|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:dateCreated |
2004-7-21
|
|
pubmed:abstractText |
The PROTEKT US (Prospective Resistant Organism Tracking and Epidemiology for the Ketolide Telithromycin in the United States) surveillance programme was started in 2000, to chart the emergence and spread of antimicrobial resistance among isolates of Streptococcus pneumoniae, Streptococcus pyogenes and Haemophilus influenzae from across the USA.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Aug
|
|
pubmed:issn |
0305-7453
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
54 Suppl 1
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
i7-15
|
|
pubmed:dateRevised |
2006-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:15265831-Anti-Infective Agents,
pubmed-meshheading:15265831-Drug Resistance, Bacterial,
pubmed-meshheading:15265831-Haemophilus influenzae,
pubmed-meshheading:15265831-Humans,
pubmed-meshheading:15265831-Longitudinal Studies,
pubmed-meshheading:15265831-Macrolides,
pubmed-meshheading:15265831-Microbial Sensitivity Tests,
pubmed-meshheading:15265831-Penicillin Resistance,
pubmed-meshheading:15265831-Population Surveillance,
pubmed-meshheading:15265831-Respiratory Tract Infections,
pubmed-meshheading:15265831-Streptococcus pneumoniae,
pubmed-meshheading:15265831-Streptococcus pyogenes,
pubmed-meshheading:15265831-United States
|
|
pubmed:year |
2004
|
|
pubmed:articleTitle |
Antimicrobial susceptibility of Streptococcus pneumoniae, Streptococcus pyogenes and Haemophilus influenzae collected from patients across the USA, in 2001-2002, as part of the PROTEKT US study.
|
|
pubmed:affiliation |
Clinical Microbiology Institute, 9725 SW Commerce Circle, Suite A1, Wilsonville, OR 97070, USA. SBrown@clinmicroinst.com
|
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|
